WallStreetZenWallStreetZen

NASDAQ: CBAN
Colony Bankcorp Inc Stock

$10.53-0.06 (-0.57%)
Updated Apr 17, 2024
CBAN Price
$10.53
Fair Value Price
$19.35
Market Cap
$184.89M
52 Week Low
$8.59
52 Week High
$13.58
P/E
8.49x
P/B
0.73x
P/S
2.12x
PEG
N/A
Dividend Yield
4.2%
Revenue
$110.28M
Earnings
$21.75M
Gross Margin
100%
Operating Margin
24.68%
Profit Margin
19.7%
Debt to Equity
10.98
Operating Cash Flow
$21M
Beta
0.71
Next Earnings
Apr 25, 2024
Ex-Dividend
N/A
Next Dividend
N/A

CBAN Overview

Colony Bankcorp, Inc. operates as the bank holding company for Colony Bank that provides various banking products and services to commercial and consumer customers. The company offers various deposit products, including demand, savings, and time deposits. It also provides loans to small and medium-sized businesses; residential and commercial construction, and land development loans; commercial real estate loans; commercial loans; agri-business and production loans; residential mortgage loans; home equity loans; and consumer loans. In addition, the company offers internet banking services, electronic bill payment services, safe deposit box rentals, telephone banking, credit and debit card services, and remote depository products, as well as access to a network of ATMs. As of January 20, 2022, it operated 39 locations throughout Georgia. The company was founded in 1975 and is headquartered in Fitzgerald, Georgia.

Zen Score

Industry Average (33)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CBAN scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CBAN ($10.53) is undervalued by 45.58% relative to our estimate of its Fair Value price of $19.35 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
CBAN ($10.53) is significantly undervalued by 45.58% relative to our estimate of its Fair Value price of $19.35 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
CBAN was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more CBAN due diligence checks available for Premium users.

Be the first to know about important CBAN news, forecast changes, insider trades & much more!

CBAN News

Valuation

CBAN fair value

Fair Value of CBAN stock based on Discounted Cash Flow (DCF)
Price
$10.53
Fair Value
$19.35
Undervalued by
45.58%
CBAN ($10.53) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CBAN ($10.53) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CBAN was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CBAN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
8.49x
Industry
-10.51x
Market
41.64x
CBAN is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CBAN is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

CBAN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.73x
Industry
0.95x
CBAN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CBAN's financial health

Profit margin

Revenue
$26.7M
Net Income
$5.6M
Profit Margin
21%
CBAN's Earnings (EBIT) of $27.21M... subscribe to Premium to read more.
Interest Coverage Financials
CBAN's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$3.1B
Liabilities
$2.8B
Debt to equity
10.98
CBAN's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CBAN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$5.8M
Investing
-$5.3M
Financing
-$58.5M
CBAN's operating cash flow ($20.98M)... subscribe to Premium to read more.
Debt Coverage Financials

CBAN vs Bank Stocks

TickerMarket Cap1d %P/EP/B
CBAN$184.89M-0.57%8.49x0.73x
BWFG$186.21M+1.16%4.98x0.70x
FVCB$186.82M+0.58%47.50x0.86x
FFNW$186.88M-0.15%29.52x1.16x
BPRN$188.09M-0.13%7.24x0.78x

Colony Bankcorp Stock FAQ

What is Colony Bankcorp's quote symbol?

(NASDAQ: CBAN) Colony Bankcorp trades on the NASDAQ under the ticker symbol CBAN. Colony Bankcorp stock quotes can also be displayed as NASDAQ: CBAN.

If you're new to stock investing, here's how to buy Colony Bankcorp stock.

What is the 52 week high and low for Colony Bankcorp (NASDAQ: CBAN)?

(NASDAQ: CBAN) Colony Bankcorp's 52-week high was $13.58, and its 52-week low was $8.59. It is currently -22.46% from its 52-week high and 22.58% from its 52-week low.

How much is Colony Bankcorp stock worth today?

(NASDAQ: CBAN) Colony Bankcorp currently has 17,558,611 outstanding shares. With Colony Bankcorp stock trading at $10.53 per share, the total value of Colony Bankcorp stock (market capitalization) is $184.89M.

Colony Bankcorp stock was originally listed at a price of $10.24 in Apr 2, 1998. If you had invested in Colony Bankcorp stock at $10.24, your return over the last 26 years would have been 2.83%, for an annualized return of 0.11% (not including any dividends or dividend reinvestments).

How much is Colony Bankcorp's stock price per share?

(NASDAQ: CBAN) Colony Bankcorp stock price per share is $10.53 today (as of Apr 17, 2024).

What is Colony Bankcorp's Market Cap?

(NASDAQ: CBAN) Colony Bankcorp's market cap is $184.89M, as of Apr 18, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Colony Bankcorp's market cap is calculated by multiplying CBAN's current stock price of $10.53 by CBAN's total outstanding shares of 17,558,611.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.